Therapeutic strategies that mimic normoxic conditions can facilitate HIF1α degradation and restore the TCA cycle, thus reducing the reliance of GBM hypoxic cells on glycolysis, impairing their survival in the oxygen-deprived tumor core [42]. Here, HIF1A is linked to neoplasm.